Samlyn Capital’s LogicBio Therapeutics, Inc. Common Stock LOGC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-1,511,417
| Closed | -$3.49M | – | 140 |
|
|
2021
Q4 | $3.49M | Buy |
1,511,417
+37,309
| +3% | +$86.2K | 0.05% | 99 |
|
|
2021
Q3 | $6.75M | Buy |
1,474,108
+53,656
| +4% | +$246K | 0.09% | 94 |
|
|
2021
Q2 | $6.31M | Buy |
1,420,452
+20,608
| +1% | +$91.5K | 0.09% | 87 |
|
|
2021
Q1 | $10.2M | Sell |
1,399,844
-17,602
| -1% | -$128K | 0.14% | 86 |
|
|
2020
Q4 | $10.8M | Buy |
1,417,446
+643,551
| +83% | +$4.91M | 0.15% | 82 |
|
|
2020
Q3 | $7.03M | Sell |
773,895
-13,120
| -2% | -$119K | 0.13% | 88 |
|
|
2020
Q2 | $6.66M | Sell |
787,015
-11,551
| -1% | -$97.7K | 0.12% | 86 |
|
|
2020
Q1 | $3.95M | Buy |
798,566
+58,520
| +8% | +$289K | 0.1% | 71 |
|
|
2019
Q4 | $5.33M | Buy |
740,046
+100,069
| +16% | +$720K | 0.11% | 82 |
|
|
2019
Q3 | $6.92M | Buy |
639,977
+1,478
| +0.2% | +$16K | 0.17% | 70 |
|
|
2019
Q2 | $8.3M | Buy |
638,499
+4,216
| +0.7% | +$54.8K | 0.18% | 80 |
|
|
2019
Q1 | $6.27M | Buy |
634,283
+84,744
| +15% | +$837K | 0.15% | 80 |
|
|
2018
Q4 | $5.72M | Buy |
+549,539
| New | +$5.72M | 0.14% | 82 |
|